Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China
· Delayed Price · Currency is CNY 12.42
+0.18 (1.47%)
Mar 10, 2026, 3:04 PM CST
1.92% (1Y)
| Market Cap | 5.19B |
| Revenue (ttm) | 430.77M |
| Net Income (ttm) | 37.82M |
| Shares Out | 417.60M |
| EPS (ttm) | 0.09 |
| PE Ratio | 137.18 |
| Forward PE | n/a |
| Dividend | 0.17 (1.41%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 2,828,569 |
| Average Volume | 4,863,028 |
| Open | 11.89 |
| Previous Close | 12.24 |
| Day's Range | 11.89 - 12.45 |
| 52-Week Range | 9.38 - 16.95 |
| Beta | 0.80 |
| RSI | 45.81 |
| Earnings Date | Mar 31, 2026 |